World Pancreatic Cancer Day 2026: Symptoms, Risk Factors, Diagnosis and Treatment

World Pancreatic Cancer Day 2026 will be observed on 19 November 2026 to increase awareness about pancreatic cancer, encourage people to recognise possible symptoms and risk factors, and promote earlier medical evaluation.

Pancreatic cancer remains one of the most difficult cancers to detect early because it often causes few or no noticeable symptoms during its initial stages. The World Pancreatic Cancer Coalition notes that pancreatic cancer continues to have a very low five-year survival rate in many parts of the world, making earlier recognition and better access to diagnosis and treatment particularly important.

The 2026 campaign encourages people to:

  • Learn the warning signs
  • Understand personal risk factors
  • Listen to persistent changes in the body
  • Seek medical attention without unnecessary delay
  • Support pancreatic-cancer research and awareness

At Metro Hospital, Faridabad, patients with unexplained jaundice, persistent upper abdominal pain, back pain, unexplained weight loss or suspected pancreatic disease can seek specialist evaluation through the Medical Gastroenterology Department. Patients who require advanced pancreatic or hepatobiliary surgery can be evaluated through the Surgical Gastroenterology Department.

For patients diagnosed with pancreatic cancer, multidisciplinary cancer care is available through Metro Cancer Institute – Medical Oncology, supported by Surgical Oncology and Radiation Oncology where clinically appropriate.

Patients with pancreatic, liver, biliary or gastrointestinal symptoms can also consult Dr. Vishal Khurana, Director & HOD – Gastroenterology at Metro Hospital, Faridabad.

This detailed guide explains World Pancreatic Cancer Day 2026, pancreatic cancer symptoms, major risk factors, diagnosis, staging, surgery, chemotherapy, molecular testing, targeted therapy and supportive treatment.

When Is World Pancreatic Cancer Day 2026?

World Pancreatic Cancer Day 2026 is observed on 19 November 2026.

Throughout November, during Pancreatic Cancer Awareness Month, the World Pancreatic Cancer Coalition coordinates global activities that culminate on World Pancreatic Cancer Day.

The campaign aims to:

  • Improve symptom awareness
  • Increase understanding of risk factors
  • Encourage earlier diagnosis
  • Improve visibility of pancreatic cancer
  • Support research
  • Encourage conversations between patients and healthcare professionals

What Is the World Pancreatic Cancer Day 2026 Campaign Message?

The 2026 campaign does not centre on a single short “theme” as some other health observances do.

Instead, the World Pancreatic Cancer Coalition is focusing on three major ideas:

  • Know the symptoms
  • Know the risks
  • Take action earlier

The coalition specifically encourages people to seek medical advice if something feels wrong because earlier diagnosis may allow more treatment options.

What Is Pancreatic Cancer?

The pancreas is an organ located deep in the upper abdomen, behind the stomach.

It has two important functions:

Digestive Function

The pancreas produces enzymes that help digest:

  • Fats
  • Proteins
  • Carbohydrates

Hormonal Function

It also produces hormones, including insulin, which help regulate blood glucose.

Pancreatic cancer develops when abnormal pancreatic cells begin to grow uncontrollably.

The majority of pancreatic cancers arise from the exocrine portion of the pancreas and are commonly classified as pancreatic ductal adenocarcinoma.

Why Is Pancreatic Cancer Difficult to Detect Early?

Pancreatic cancer is challenging because early disease often causes few or no symptoms.

The pancreas also lies deep in the abdomen, making small tumours difficult to detect during routine physical examinations.

NCI notes that pancreatic cancer generally has no obvious early symptoms, and many symptoms appear only after the disease has progressed.

This is why awareness of subtle warning signs matters.

Early Signs and Symptoms of Pancreatic Cancer

Pancreatic cancer symptoms depend on:

  • Tumour location
  • Tumour size
  • Whether the bile duct is blocked
  • Whether the disease has spread

Common symptoms may include the following.

1. Jaundice

Jaundice causes:

  • Yellowing of the skin
  • Yellowing of the whites of the eyes

A tumour in the head of the pancreas may block the bile duct, causing bilirubin to accumulate in the bloodstream.

NCI lists jaundice as one of the key symptoms of pancreatic cancer.

2. Dark Urine

When bile flow is obstructed, urine may become unusually dark.

Patients may describe it as:

  • Tea-coloured
  • Brownish
  • Very dark yellow

Dark urine with yellowing of the skin or eyes should be evaluated by a doctor.

3. Pale or Light-Coloured Stool

A blocked bile duct can prevent bile from reaching the intestine normally.

This can make stools appear:

  • Pale
  • Grey
  • Clay-coloured

NCI includes light-coloured stools among the symptoms associated with pancreatic cancer.

4. Itchy Skin

Bile salts building up in the bloodstream may cause significant itching.

This may accompany:

  • Jaundice
  • Dark urine
  • Pale stools

5. Upper Abdominal Pain

Pancreatic cancer may cause pain in the upper or middle abdomen.

It may be:

  • Dull
  • Persistent
  • Progressive

In some patients, the pain worsens after eating.

6. Back Pain

Pancreatic tumours can cause pain that radiates from the abdomen toward the back.

NCI lists upper or middle abdominal pain and back pain among possible symptoms.

Persistent abdominal and back pain should not repeatedly be assumed to be gas or acidity without evaluation.

7. Unexplained Weight Loss

Weight loss without dieting is an important warning sign.

It may occur because cancer affects:

  • Appetite
  • Digestion
  • Metabolism
  • Nutrient absorption

8. Loss of Appetite

A patient may notice:

  • Less interest in food
  • Feeling full quickly
  • Reduced meal size

Persistent loss of appetite with unexplained weight loss requires assessment.

9. Fatigue

Pancreatic cancer may cause persistent weakness or fatigue.

NCI identifies fatigue among the possible symptoms of pancreatic cancer.

10. Nausea and Vomiting

If a tumour presses on the stomach or upper intestine, it can affect food passage and contribute to:

  • Nausea
  • Vomiting
  • Poor appetite

11. Bloating or Gas

Some patients may experience:

  • Abdominal fullness
  • Bloating
  • Gas

These symptoms are very common and usually have non-cancerous causes.

However, persistent bloating with weight loss or jaundice should not be ignored.

12. New-Onset Diabetes

New diabetes in later life can occasionally be associated with pancreatic cancer.

NCI notes that a new diagnosis of diabetes in someone without typical risk factors may sometimes be an early sign, particularly when accompanied by other concerning symptoms.

Most new diabetes cases are not caused by pancreatic cancer, but the combination of:

  • New diabetes
  • Unexplained weight loss
  • Abdominal pain
  • Jaundice

may warrant further evaluation.

13. Blood Clots

Advanced pancreatic cancer can increase the tendency for blood to clot.

Possible symptoms include:

  • Swollen painful leg
  • Sudden shortness of breath

NCI notes that newly diagnosed blood clots may be associated with pancreatic cancer in some patients.

Major Risk Factors for Pancreatic Cancer

The exact cause is not known in most cases, but several risk factors are recognised.

1. Smoking

Cigarette smoking increases pancreatic cancer risk.

Stopping smoking is one of the most important modifiable preventive measures.

2. Obesity

Obesity is associated with increased risk.

Maintaining a healthy weight may help reduce overall cancer and metabolic risk.

3. Chronic Pancreatitis

Long-standing pancreatic inflammation can increase the risk of pancreatic cancer.

NCI identifies chronic pancreatitis as an established risk factor.

4. Family History

People with a family history of pancreatic cancer may have a higher risk.

The risk is particularly important when several close relatives are affected.

5. Genetic Mutations

Inherited gene changes associated with increased risk include:

  • BRCA1
  • BRCA2
  • PALB2
  • ATM

NCI identifies these genes among recognised inherited pancreatic-cancer risk factors.

6. Diabetes

Long-standing diabetes is associated with increased pancreatic-cancer risk.

At the same time, pancreatic cancer can occasionally cause new-onset diabetes.

Can Pancreatic Cancer Be Prevented?

Not every case can be prevented.

However, risk reduction may include:

  • Avoiding smoking
  • Maintaining a healthy body weight
  • Staying physically active
  • Managing diabetes appropriately
  • Following a balanced diet
  • Limiting excessive alcohol

People with a strong family history or inherited cancer-risk syndrome should discuss genetic counselling and surveillance with a specialist.

Is There Routine Screening for Pancreatic Cancer?

Routine screening is not recommended for average-risk adults.

Unlike some cancers, there is no standard population screening programme for pancreatic cancer.

Higher-risk individuals with:

  • Strong family history
  • Certain genetic mutations

may be considered for specialist surveillance.

Depending on individual risk, surveillance may involve:

  • MRI/MRCP
  • Endoscopic ultrasound

How Is Pancreatic Cancer Diagnosed?

Diagnosis usually begins with:

  • Medical history
  • Physical examination
  • Blood tests
  • Imaging

NCI states that imaging tests are central to both diagnosing pancreatic cancer and determining its stage.

Blood Tests

Blood tests may include:

  • Bilirubin
  • Liver enzymes
  • Blood glucose
  • Complete blood count

These tests do not diagnose pancreatic cancer by themselves but may identify abnormalities related to bile-duct obstruction or general health.

CA 19-9 Tumour Marker

CA 19-9 can be elevated in some pancreatic cancers.

However, it is not suitable as a general population screening test.

It can also rise in:

  • Bile-duct obstruction
  • Pancreatitis
  • Other gastrointestinal conditions

NCI notes that tumour-marker measurements can help assess disease burden and treatment response when elevated.

CT Scan

A contrast-enhanced CT scan is one of the most important diagnostic and staging tools.

It can help assess:

  • Tumour size
  • Tumour location
  • Blood-vessel involvement
  • Lymph nodes
  • Distant spread

MRI and MRCP

MRI can provide detailed images of the pancreas and surrounding structures.

MRCP can help evaluate:

  • Bile ducts
  • Pancreatic ducts

Endoscopic Ultrasound

Endoscopic ultrasound, or EUS, allows close examination of the pancreas using an ultrasound probe attached to an endoscope.

It may also help obtain biopsy samples.

At Metro Hospital, Faridabad, the Medical Gastroenterology programme provides advanced endoscopic evaluation, including EUS for selected pancreatic and biliary disorders.

ERCP

ERCP may be used when a pancreatic tumour blocks the bile duct.

It can help:

  • Evaluate the bile duct
  • Relieve obstruction
  • Place a stent
  • Obtain selected tissue samples

NCI lists ERCP among procedures that may assist in the diagnosis of pancreatic cancer, particularly in the presence of bile-duct obstruction.

Biopsy

A biopsy removes tissue so a pathologist can confirm whether cancer is present.

Biopsy can be obtained using:

  • Endoscopic ultrasound
  • Image-guided needle biopsy
  • Other procedures depending on tumour location

Molecular Testing

Molecular testing has become increasingly important in pancreatic cancer.

NCI recommends molecular profiling because certain gene changes may create opportunities for targeted treatments.

Testing may identify alterations involving:

  • KRAS
  • BRCA
  • PALB2
  • NTRK
  • Other actionable mutations

Genetic Testing

Genetic testing can identify inherited mutations that may:

  • Affect treatment
  • Help estimate family risk
  • Guide genetic counselling

People diagnosed with pancreatic cancer may be advised to discuss germline genetic testing with their treating team.

How Is Pancreatic Cancer Staged?

Pancreatic cancer is often described according to whether it is:

Resectable

The tumour appears removable with surgery.

Borderline Resectable

The tumour may involve nearby blood vessels but could potentially become operable after treatment.

Locally Advanced

The cancer has significant local involvement and usually cannot initially be completely removed.

Metastatic

The cancer has spread to distant organs.

Treatment depends heavily on these categories.

Can Pancreatic Cancer Be Cured?

Some patients with early, surgically removable pancreatic cancer can be treated with curative intent.

However, surgery is possible only for a proportion of patients because many cases are diagnosed at a more advanced stage.

Earlier evaluation therefore matters.

Surgery for Pancreatic Cancer

Surgery remains a key treatment for resectable pancreatic cancer.

Whipple Procedure

The Whipple procedure, or pancreaticoduodenectomy, is commonly used for tumours in the head of the pancreas.

It may involve removal of:

  • Head of pancreas
  • Gallbladder
  • Part of the small intestine
  • Part of the bile duct
  • Sometimes part of the stomach

NCI describes the Whipple procedure as a standard surgical approach for tumours in the pancreatic head.

Distal Pancreatectomy

A distal pancreatectomy is commonly used for tumours in the:

  • Body
  • Tail

of the pancreas.

The spleen may also need to be removed in some cases.

Total Pancreatectomy

In selected cases, the entire pancreas may need to be removed.

Patients then require lifelong management of:

  • Diabetes
  • Digestive enzyme deficiency

Pancreatic Cancer Surgery at Metro Hospital

At Metro Hospital, Faridabad, the Surgical Gastroenterology and Surgical Oncology teams manage pancreatic surgery.

The hospital’s Surgical Oncology services include pancreatic resections such as pancreatectomy as part of gastrointestinal cancer surgery, while Surgical Gastroenterology supports the management of pancreatic and hepatobiliary conditions.

Chemotherapy for Pancreatic Cancer

Chemotherapy may be used:

  • Before surgery
  • After surgery
  • For borderline-resectable disease
  • For locally advanced cancer
  • For metastatic disease

Treatment choice depends on:

  • Stage
  • Age
  • General health
  • Performance status
  • Molecular findings

At Metro Cancer Institute, Medical Oncology provides systemic cancer treatment for solid tumours, including gastrointestinal cancers.

Neoadjuvant Therapy

Neoadjuvant treatment is given before surgery.

It may help:

  • Shrink the tumour
  • Treat microscopic disease
  • Improve surgical options in selected patients

Adjuvant Therapy

Adjuvant chemotherapy is given after surgery to reduce the risk of recurrence.

Targeted Therapy

Targeted therapy is becoming increasingly important in selected pancreatic cancers.

NCI’s current guidance lists several molecularly targeted options for specific mutations and tumour profiles.

This reinforces the importance of molecular testing.

KRAS-Targeted Treatment

KRAS mutations are extremely common in pancreatic cancer.

NCI’s 2026 pancreatic-cancer treatment update notes the approval of daraxonrasib for certain advanced, previously treated pancreatic cancers with KRAS mutations.

This does not mean the treatment is appropriate for every patient.

Eligibility depends on:

  • Specific mutation
  • Treatment history
  • Clinical condition
  • Regulatory availability

Immunotherapy

Immunotherapy has a role in only a small proportion of pancreatic cancers.

Patients with certain molecular features may benefit.

Testing is therefore important before deciding whether immunotherapy is suitable.

Radiation Therapy

Radiation therapy may be considered for selected patients with:

  • Locally advanced disease
  • Borderline-resectable disease
  • Persistent local tumour
  • Pain or symptom control

At Metro Cancer Institute, the Radiation Oncology team can coordinate radiation treatment depending on clinical need.

Supportive and Palliative Care

Supportive care is important at every stage.

It may include:

  • Pain management
  • Nutrition support
  • Bile-duct stenting
  • Pancreatic enzyme replacement
  • Diabetes management
  • Psychological support

Bile-Duct Stenting

If a pancreatic tumour blocks bile flow and causes jaundice, an endoscopic stent may be placed to relieve obstruction.

This can help improve:

  • Jaundice
  • Itching
  • Liver-function abnormalities

Pancreatic Enzyme Replacement

Some patients develop pancreatic exocrine insufficiency.

This can lead to:

  • Weight loss
  • Oily stools
  • Bloating
  • Poor absorption

Pancreatic enzyme replacement may improve digestion in selected patients.

Nutrition in Pancreatic Cancer

Patients may struggle with:

  • Poor appetite
  • Weight loss
  • Malabsorption

Nutrition plans may involve:

  • Smaller frequent meals
  • Higher protein intake
  • Energy-dense foods
  • Pancreatic enzymes when prescribed

Diet should be individualised.

Why Multidisciplinary Care Matters

Pancreatic cancer treatment often involves multiple specialists, including:

  • Gastroenterologist
  • Surgical gastroenterologist
  • Surgical oncologist
  • Medical oncologist
  • Radiation oncologist
  • Radiologist
  • Pathologist
  • Nutrition specialist

A multidisciplinary approach helps coordinate:

  • Diagnosis
  • Staging
  • Surgery
  • Chemotherapy
  • Radiation
  • Supportive care

Pancreatic Cancer Care at Metro Hospital, Faridabad

Patients with suspected pancreatic disease can begin evaluation through the Medical Gastroenterology Department at Metro Hospital, Faridabad.

Relevant services can include:

  • Endoscopic evaluation
  • EUS
  • ERCP
  • Evaluation of jaundice
  • Assessment of unexplained abdominal pain
  • Pancreatic and biliary investigations

Patients requiring surgery may be managed through:

  • Surgical Gastroenterology
  • Surgical Oncology

while systemic cancer treatment can be coordinated through:

  • Medical Oncology
  • Metro Cancer Institute

This integrated approach allows diagnosis, staging and treatment planning to take place within a multidisciplinary care pathway.

When Should You See a Doctor?

Seek medical evaluation if you develop:

  • Unexplained jaundice
  • Persistent upper abdominal pain
  • Persistent back pain
  • Unexplained weight loss
  • Loss of appetite
  • Dark urine
  • Pale stools
  • New-onset diabetes with unexplained weight loss
  • Persistent nausea or vomiting

These symptoms do not necessarily mean pancreatic cancer, but they should be investigated.

Common Myths About Pancreatic Cancer

Myth 1: Pancreatic Cancer Always Causes Severe Pain Early

False.

Early pancreatic cancer may cause no symptoms.

Myth 2: Jaundice Always Means Liver Disease

False.

Jaundice can also result from blockage of the bile duct by a pancreatic tumour.

Myth 3: Only Smokers Get Pancreatic Cancer

False.

Smoking increases risk, but pancreatic cancer also occurs in non-smokers.

Myth 4: Pancreatic Cancer Cannot Be Treated

False.

Treatment may include:

  • Surgery
  • Chemotherapy
  • Radiation
  • Targeted therapy
  • Supportive care

Depending on stage.

Myth 5: Every New Diabetes Diagnosis Means Pancreatic Cancer

False.

Most people with newly diagnosed diabetes do not have pancreatic cancer.

However, new diabetes associated with unexplained weight loss or other warning signs may need further evaluation.

Frequently Asked Questions About World Pancreatic Cancer Day 2026

1. When is World Pancreatic Cancer Day 2026?

World Pancreatic Cancer Day 2026 is observed on 19 November 2026.

2. What is the theme of World Pancreatic Cancer Day 2026?

The 2026 campaign focuses on raising awareness of symptoms and risk factors, encouraging earlier diagnosis and inspiring action to improve outcomes rather than promoting a single short official theme.

3. What are the early signs of pancreatic cancer?

Pancreatic cancer often has no clear early symptoms. Possible symptoms include jaundice, abdominal or back pain, unexplained weight loss, dark urine, pale stools and loss of appetite.

4. Can pancreatic cancer cause back pain?

Yes. Pain in the upper or middle abdomen that radiates to the back can occur.

5. Can pancreatic cancer cause diabetes?

Pancreatic cancer can sometimes be associated with new-onset diabetes, although most people with diabetes do not have pancreatic cancer.

6. What are the main risk factors?

Risk factors include smoking, obesity, chronic pancreatitis, family history and certain inherited mutations such as BRCA1, BRCA2, PALB2 and ATM.

7. How is pancreatic cancer diagnosed?

Diagnosis may include CT, MRI, EUS, ERCP, blood tests and biopsy. Molecular and genetic testing may also be recommended.

8. Can pancreatic cancer be surgically removed?

Some pancreatic cancers can be removed when diagnosed at a resectable stage. Procedures may include the Whipple operation or distal pancreatectomy.

9. Is targeted therapy available for pancreatic cancer?

Yes, but only for selected patients with specific molecular alterations. Molecular testing is important because it may identify actionable mutations.

10. Where can I get pancreatic cancer treatment in Faridabad?

Patients can seek multidisciplinary evaluation and treatment at Metro Hospital and Metro Cancer Institute, Faridabad, with support from Medical Gastroenterology, Surgical Gastroenterology, Surgical Oncology, Medical Oncology and Radiation Oncology.

Conclusion

World Pancreatic Cancer Day 2026 will be observed on 19 November 2026.

The World Pancreatic Cancer Coalition is using the day to raise awareness of one of the most difficult cancers to diagnose early and to encourage people to recognise symptoms, understand risk factors, and seek medical advice sooner.

Important warning signs include:

  • Jaundice
  • Dark urine
  • Pale stools
  • Upper abdominal pain
  • Back pain
  • Unexplained weight loss
  • Loss of appetite
  • Persistent nausea
  • Fatigue
  • New-onset diabetes in selected circumstances

Pancreatic cancer is difficult to detect early, but earlier diagnosis may provide more treatment options.

Modern treatment can involve:

  • Surgery
  • Chemotherapy
  • Radiation therapy
  • Molecular testing
  • Targeted therapy
  • Supportive care

At Metro Hospital, Faridabad, patients with suspected pancreatic disease can be evaluated through Medical Gastroenterology and Surgical Gastroenterology, while confirmed pancreatic cancer can be treated through Metro Cancer Institute, supported by Surgical Oncology, Medical Oncology and Radiation Oncology.

The most important message for World Pancreatic Cancer Day 2026 is:

Know the symptoms, understand the risks, and do not ignore persistent unexplained changes—earlier evaluation can make an important difference.

Disclaimer: This article is intended for general health education only. Pancreatic cancer cannot be diagnosed from symptoms alone. Persistent jaundice, unexplained weight loss, abdominal or back pain, or other concerning symptoms should be evaluated by a qualified healthcare professional.